BioRestorative Therapies

116 articles with BioRestorative Therapies

• BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain

  12/16/2019

  BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced today feature coverage in the news outlet, IEEE Pulse, a magazine of the IEEE Engineering in Medicine and Biology Society.

• BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

  12/12/2019

  This is the eighth patent issued, in the United States and other countries, for the Company’s brown fat technology related to BioRestorative’s metabolic program

• BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

  10/23/2019

  This patent will allow for the protection of a specific isolated human brown adipose tissue stem cell line capable of differentiating into multiple cell types.

• BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development

  1/22/2018

  In this capacity, Mr. Bergstein will be responsible for strategic planning, business development, capital market activities and related endeavors.

• BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan

  10/17/2017

  The patent will allow for a method of isolating and differentiating a non-embryonic human brown adipose-derived stem cell into functional human brown adipocytes.

• BioRestorative Announces Published Study Of Licensed Technology To Treat Lumbar Degenerative Disc Disease

  10/5/2017

• BioRestorative Receives Notice Of Acceptance For Key Metabolic Patent In Australia

  4/20/2017

• BioRestorative Names Lead Cell-Based Lumbar Disc Therapeutic Product

  2/9/2016

• BioRestorative Appoints John M. Desmarais, J.D. To Its Board Of Directors

  12/2/2015

• BioRestorative Granted Key Metabolic Patent

  11/19/2015

• BioRestorative Announces Patent Granted For Its Licensed Curved Needle Device

  11/3/2015

• BioRestorative To Evaluate Cell Delivery Technology To Advance Metabolic Program Towards Human Trials

  7/20/2015

• BioRestorative Announces Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ Capital Market

  7/7/2015

• BioRestorative Announces Conversion Of $5.15 Million Of Debt To Equity

  6/2/2015

• BioRestorative To Present Thermostem Data At 21st Annual Meeting Of The International Society For Cellular Therapy

  5/27/2015

• BioRestorative To Present At The 2015 Marcum Microcap Conference In New York City

  5/26/2015

• BioRestorative Shutters Florida Office and Opens New HQ and Lab in New York

  4/14/2015

• BioRestorative Therapies, Inc. Appoints Charles S. Ryan, J.D., Ph.D. To Its Board Of Directors

  4/8/2015

• BioRestorative Therapies, Inc. Announces The Appointment Of Edward Field As President Of The Brtxdisc Division

  2/17/2015

• BioRestorative Therapies, Inc. To Present At Inaugural Innovations Conference

  2/5/2015